TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
QGEN

Qiagen NV

Healthcare · Diagnostics & Research

44.80$ +6.4% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Cash Flow

Qiagen NV (QGEN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at 201 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow QGEN
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
94 100 60 69 81 76 48 118 83 111 45 82 94 109 16 135 37 270 129 156 156 198 207 172 212 124 72 111 125 151 133 167 182 192 140 161 165 188 101 201 654
53 56 55 57 52 53 53 55 49 50 59 62 57 53 48 49 51 57 56 55 53 51 53 50 50 55 52 51 51 52 54 53 50 46 44 49 52 49 51 51 203
7.9 5.3 8.9 10 8.6 6.8 10 9.2 11 9.5 11 12 35 7.9 8.7 7.8 15 9.7 9.7 9.6 12 7.0 12 11 13 14 14 7.9 13 12 14 10 8.9 11 12 11 11 17 9.7 7.0 44
– 19 7.3 9.5 5.5 93 7.5 11 11 -7.4 9.4 -4.1 171 -32 16 4.4 -7.1 -89 -24 18 -11 60 14 13 3.2 -125 14 14 17 – – – – – – – – – – – –
-8.4 19 -25 -16 -31 -16 -53 6.5 -46 -3.1 -66 -30 17 34 -98 -14 -39 78 -40 -45 -27 -17 -23 3.8 67 -80 -74 -44 -29 -41 -18 106 17 31 -15 -4.1 -26 11 -42 39 -19
21 26 24 32 35 33 34 32 37 48 153 36 36 50 28 122 88 67 55 46 51 54 38 38 27 47 38 31 41 52 38 39 44 50 44 41 46 71 47 43 207
-56 -16 -12 -68 -292 -92 109 -229 -112 21 -171 42 -13 -81 13 -80 -322 -55 106 -185 -219 95 -306 -252 -44 -125 -434 156 248 -58 6.4 -18 -231 -6.8 120 -42 -157 -226 211 -70 -242
– – 244 – 472 307 – – – 567 – – – 74 – – – 438 – – – 41 – – 363 0.5 – – – – – – – – – – 54 0.0 – – –
– 6.3 -244 1.1 -61 305 -21 -21 -46 -38 -44 -30 -0.1 74 -0.5 -0.5 -7.0 -64 -13 -13 -82 -18 -7.7 -9.0 -8.2 -0.5 – -13 -4.7 -0.5 -292 -27 -6.2 -0.9 -280 -10 -9.3 -2.7 -497 – –
– -8.1 -0.4 300 426 723 -0.3 -0.3 -0.3 495 -433 -207 -207 -207 -45 -45 70 -60 -41 – – 371 371 371 371 -507 -437 -437 -437 – – – 496 -502 – – 684 -476 – – –
-11 5.2 -244 293 338 1.2 -2.2 -23 -42 428 -480 -54 -2.2 -103 9.4 -26 59 -93 -41 -2.6 -76 -31 -11 23 408 -546 -9.8 -15 -401 -7.4 -292 -127 486 -489 -287 -28 614 -478 -504 -8.5 -376
26 85 -194 297 129 -14 157 -141 -75 559 -606 72 76 -71 32 30 -223 129 190 -29 -142 263 -110 -64 565 -541 -371 250 -30 88 -154 20 439 -309 -25 95 622 -517 -193 122 35
73 74 36 38 46 43 14 86 46 63 -108 46 58 59 -12 13 -50 203 74 110 104 144 169 134 185 78 34 80 84 99 95 128 138 142 96 121 119 117 54 158 448

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?